# Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease

> **NCT03587701** · PHASE2 · RECRUITING · sponsor: **Northwell Health** · enrollment: 57 (estimated)

## Conditions studied

- Autoimmune Inner Ear Disease
- Meniere's Disease

## Interventions

- **DRUG:** Anakinra 100Mg/0.67Ml Inj Syringe (Period 1)
- **DRUG:** Placebo injection (Period 1)
- **DRUG:** Anakinra 100Mg/0.67Ml Inj Syringe (Period 2)
- **DRUG:** Placebo injection (Period 2)

## Key facts

- **NCT ID:** NCT03587701
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-01-03
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 57 (ESTIMATED)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03587701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03587701, "Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03587701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*